U.S. Pharmacopeia Verifies Quality Of First Traditional Chinese Medicine Ingredient Under Voluntary Program
This article was originally published in PharmAsia News
Executive Summary
BEIJING - In an effort to partner with manufacturers to elevate the quality of traditional Chinese medicines sold in the U.S. and worldwide, the United States Pharmacopeial Convention recently verified for the first time ever one of the ingredients used in these medicines
You may also be interested in...
Safety Of Traditional Chinese Medicine Injections Questioned Following Three Deaths
SHANGHAI - Three deaths caused by adverse drug reactions allegedly linked to use of herbal injection Shuanghuanglian have raised wider concerns over the safety of herbal injections in China
Safety Of Traditional Chinese Medicine Injections Questioned Following Three Deaths
SHANGHAI - Three deaths caused by adverse drug reactions allegedly linked to use of herbal injection Shuanghuanglian have raised wider concerns over the safety of herbal injections in China
U.S. Pharmacopeia Ramps Up Drug Quality, Safety Cooperation Across Asia With Four New Agreements With China, ASEAN States
BEIJING - In moves that could ultimately help elevate safety and quality standards for drugs produced across Asia, including those exported to North America, the United States Pharmacopeial Convention has signed a series of agreements with China and the Association of Southeast Asian Nations on closer scientific exchanges and joint testing of pharmaceuticals